Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Essential,Hypertension”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableEnrolling By InvitationNCT07399912
What this trial is testing

Engaging Home-monitored Assessment to Navigate Clinical Decision-making

Who this might be right for
Hypertension,Essential
SingHealth Polyclinics 116
Not applicableNot Yet RecruitingNCT06316271
What this trial is testing

Endothelial Function in Prehypertension

Who this might be right for
Hypertension,Essential
Josip Juraj Strossmayer University of Osijek 90
Not applicableUnknownNCT06084065
What this trial is testing

Feasibility and Effectiveness of a Ring-type Blood Pressure Measurement Device

Who this might be right for
HypertensionBlood PressureSystolic Hypertension+4 more
Seoul National University Hospital 40
Large-scale testing (Phase 3)Study completedNCT00219128
What this trial is testing

A Dose Ranging Study to Compare the Safety and Efficacy of Aliskiren 150mg, 300mg, and 600mg to Placebo in Patients With High Blood Pressure.

Who this might be right for
Hypertension
Novartis 671
Post-approval studies (Phase 4)Study completedNCT00328965
What this trial is testing

Lacidipine In Mild To Moderate Essential Hypertension Patients With Type 2 Diabetes In Korea

Who this might be right for
Diabetes Mellitus, Type 2Essential Hypertension
GlaxoSmithKline
Not applicableUnknownNCT04103411
What this trial is testing

Effect of High-Intensity Interval Training Compared to Hydrochlorothiazide on Ambulatory Blood Pressure

Who this might be right for
Hypertension,EssentialExercise Activity
Anil Nigam 60
Post-approval studies (Phase 4)UnknownNCT02214498
What this trial is testing

Treatment of HYpertension: Morning Versus Evening

Who this might be right for
Essential Hypertension
Erasmus Medical Center 120
Not applicableLooking for participantsNCT07310992
What this trial is testing

Effect of Meditation as an Adjunct to Cardiac Rehabilitation

Who this might be right for
High Blood Pressure (& [Essential Hypertension])Meditation TrainingRehabilitation Exercise
Instituto Dante Pazzanese de Cardiologia 80
Large-scale testing (Phase 3)Study completedNCT00696384
What this trial is testing

A Safety and Tolerability Study of Azilsartan Medoxomil in Participants With Essential Hypertension

Who this might be right for
Hypertension
Takeda 418
Large-scale testing (Phase 3)Study completedNCT00368277
What this trial is testing

A Safety and Efficacy Trial of Aliskiren 150mg , 300 mg Compared to Ramipril 5mg, 10mg in the Elderly

Who this might be right for
Hypertension
Novartis Pharmaceuticals 901
Post-approval studies (Phase 4)Ended earlyNCT01132768
What this trial is testing

The Confirmatory Olmesartan Plaque Regression Study

Who this might be right for
Essential HypertensionCarotid Plaque
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company 114
Large-scale testing (Phase 3)Study completedNCT06174766
What this trial is testing

Evaluate Efficacy and Safety of HGP2304 in Essential Hypertension Patients

Who this might be right for
Hypertension
Hanmi Pharmaceutical Company Limited 356
Not applicableLooking for participantsNCT07383220
What this trial is testing

Effect of Electrical Stimulation and Exercise on Blood Flow in Patients With Resistant High Blood Pressure

Who this might be right for
Resistant HypertensionHemodynamic InstabilityEssential (Primary) Hypertension+5 more
Mohamed Mohamed Ali Morgan 50
Post-approval studies (Phase 4)Study completedNCT02499822
What this trial is testing

REducing Blood Pressure Variability in Essential Hypertension With RAmipril vErsus Nifedipine GITS Trial

Who this might be right for
HypertensionHigh Blood Pressure Variability
Istituto Auxologico Italiano 168
Large-scale testing (Phase 3)Study completedNCT00219141
What this trial is testing

Aliskiren in Combination With Losartan Compared to Losartan on the Regression of Left Ventricular Hypertrophy in Overweight Patients With Essential Hypertension

Who this might be right for
HypertensionLeft Ventricular HypertrophyOverweight
Novartis Pharmaceuticals 460
Large-scale testing (Phase 3)Study completedNCT00220220
What this trial is testing

Amlodipine as add-on to Olmesartan in Hypertension

Who this might be right for
Essential Hypertension
Sankyo Pharma Gmbh 429
Large-scale testing (Phase 3)Study completedNCT00461903
What this trial is testing

Efficacy of Perindopril to Prevent Recurrence of Atrial Fibrillation in Patients With Essential Hypertension

Who this might be right for
Essential HypertensionAtrial Fibrillation
Montreal Heart Institute 316
Large-scale testing (Phase 3)Study completedNCT00529451
What this trial is testing

Safety and Efficacy of Aliskiren 300 mg, 150 mg and 75 mg in Patients With Essential Hypertension Compared to Ramipril 5 mg

Who this might be right for
Hypertension
Novartis 1,613
Not applicableStudy completedNCT01650402
What this trial is testing

Intensive Versus Standard Blood Pressure Lowering to Prevent Functional Decline in Older People

Who this might be right for
Hypertension, SystolicCerebrovascular Disease
UConn Health 199
Not applicableLooking for participantsNCT05413057
What this trial is testing

An OS to Evaluate Effectiveness and Safety of Fixed-dose Combinations of FMS/AML or FMS/AML/HCTZ

Who this might be right for
Hypertension,Essential
Boryung Pharmaceutical Co., Ltd 20,000
Next Page